Mark E. Dmytruk is See remarks at Ginkgo Bioworks Holdings, Inc. (DNA). They have made 34 open-market trades across 1 company since 2022, most recently 2025-05-21.
CIK 0001873507
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 34 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNA | 46,226 | $475K |
Shares reported on the most recent Form 4, priced at the 2025-05-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNA | SELL | 2025-05-21 | 2025-05-22 | $7.59 | $5K | +12.0% | +26.4% | +71.7% |
| DNA | SELL | 2025-04-21 | 2025-04-23 | $7.28 | $9K | -9.9% | -9.0% | +73.8% |
| DNA | SELL | 2025-03-04 | 2025-03-06 | $7.73 | $6K | -6.1% | -17.3% | -2.5% |
| DNA | SELL | 2025-02-04 | 2025-02-06 | $13.44 | $10K | -8.8% | -50.0% | -46.8% |
| DNA | SELL | 2025-01-06 | 2025-01-08 | $11.72 | $8K | +19.7% | +32.2% | -46.6% |
| DNA | SELL | 2024-12-04 | 2024-12-05 | $9.64 | $7K | -1.9% | +18.9% | -15.7% |
| DNA | SELL | 2024-11-04 | 2024-11-06 | $7.58 | $10K | -24.6% | +39.0% | +70.3% |
| DNA | SELL | 2024-10-04 | 2024-10-08 | $8.35 | $10K | +7.4% | +1.3% | +40.9% |
| DNA | SELL | 2024-09-12 | 2024-09-16 | $6.17 | $7K | +20.9% | +29.8% | +48.0% |
| DNA | SELL | 2024-08-02 | 2024-08-06 | $0.29 | $18K | -23.5% | -47.0% | -34.1% |
| DNA | SELL | 2024-07-02 | 2024-07-05 | $0.33 | $16K | -0.4% | -8.9% | -39.1% |
| DNA | SELL | 2024-06-03 | 2024-06-05 | $0.55 | $27K | -17.9% | -36.1% | -70.8% |
| DNA | SELL | 2024-05-02 | 2024-05-06 | $0.85 | $41K | -16.1% | -47.9% | -69.6% |
| DNA | SELL | 2024-04-02 | 2024-04-04 | $1.05 | $107K | -13.8% | -6.8% | -64.6% |
| DNA | SELL | 2024-03-04 | 2024-03-06 | $1.26 | $49K | -10.7% | -11.5% | -56.6% |
| DNA | SELL | 2024-02-02 | 2024-02-06 | $1.21 | $48K | +14.8% | -6.3% | -22.8% |
| DNA | SELL | 2024-01-03 | 2024-01-05 | $1.54 | $141K | -22.9% | -20.3% | -30.1% |
| DNA | SELL | 2023-12-04 | 2023-12-06 | $1.39 | $118K | +20.6% | +16.8% | -12.2% |
| DNA | SELL | 2023-11-02 | 2023-11-06 | $1.50 | $112K | -2.7% | -13.3% | -18.7% |
| DNA | SELL | 2023-10-02 | 2023-10-04 | $1.76 | $149K | +1.5% | -0.9% | +0.9% |
| DNA | SELL | 2023-09-05 | 2023-09-06 | $2.24 | $186K | -15.1% | -21.1% | -40.4% |
| DNA | SELL | 2023-08-02 | 2023-08-04 | $2.07 | $193K | -24.5% | +4.2% | -28.7% |
| DNA | SELL | 2023-07-03 | 2023-07-06 | $1.80 | $146K | +37.4% | +21.6% | -4.1% |
| DNA | SELL | 2023-06-02 | 2023-06-06 | $1.57 | $127K | +1.1% | -8.5% | +19.7% |
| DNA | SELL · 10b5-1 | 2023-05-22 | 2023-05-24 | $1.50 | $375K | +8.9% | +1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.